Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: A comparison with cromakalim and nitroglycerin

Journal of Cardiovascular Pharmacology

Volumn 33, Issue 1, 1999, Pages 93-101

  Kamijo, Takeshi ^a   Kamei, Kenshi ^a   Sugo, Izumi ^a   Kamiyama, Toru ^a   Sudo, Hirokazu ^a   Ohba, Yasuhiro ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

ANP; BNP; Cromakalim; Embolization; Hemodynamics; Ischemic heart failure; Nicorandil; Nitroglycerin; PRA

Indexed keywords

CROMAKALIM; GLYCERYL TRINITRATE; NICORANDIL; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CHANNEL GATING; DOG; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ENDDIASTOLIC PRESSURE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL;

ACUTE DISEASE; ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIAC OUTPUT, LOW; CROMAKALIM; DOGS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEMODYNAMIC PROCESSES; HORMONES; MALE; MICROSPHERES; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; NICORANDIL; NITROGLYCERIN; POTASSIUM CHANNELS; RENIN; VASODILATOR AGENTS;

EID: 0032898966     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199901000-00014     Document Type: Article

References (29)

1. Sumimoto K, Domae M, Yamanaka K, et al. Actions of nicorandil on vascular smooth muscles. J Cardiovasc Pharmacol 1987; 10(suppl 8):S66-75.
2. Lefer DJ, Lefer AM. Studies on the mechanism of the vasodilator action of nicorandil. Life Sci 1988;42:1907-14.
3. Holzmann S. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75). J Cardiovasc Pharmacol 1983; 5:364-70.
4. Solal AC, Jaeger P, Bouthier J, Juliard JM, Dahan M, Gourgon R. Hemodynamic action of nicorandil in chronic congestive heart failure. Am J Cardiol 1989;63:44J-8J.
5. Tice FD, Binkley PF, Cody RJ, et al. Hemodynamic effects of oral nicorandil in congestive heart failure. Am J Cardiol 1990;65: 1361-7.
6. Giles TD, Pina IL, Quiroz AC, et al. Hemodynamic and neurohumoral responses to intravenous nicorandil in congestive heart failure in humans. J Cardiovasc Pharmacol 1992;20:572-8.
7. Tsutamoto T, Kinoshita K, Hisanaga T, et al. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure. Am J Cardiol 1995;75:1162-5.
8. Kamijo T, Tomaru T, Miwa AY, Nakamura F, Kido H, Uchida Y. Hemodynamic effects of nicorandil on acute congestive heart failure in dogs. Asia Pac J Pharmacol 1996;11:141-8.
9. + channels in arterial smooth muscle. Science 1989;245:177-80.
10. Burnett JC Jr, Kao PC, Hu DC, et al. Atrial Natriuretic peptide elevation in congestive heart failure in the human. Science 1986;231:1145-7.
11. Mukoyama K, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991;87:1402-12.
12. Raff GL, Glantz SA. Volume loading slows left ventricular isovolumic relaxation rate: evidence of load-dependent relaxation in the intact dog heart. Circ Res 1981;48:813-24.
13. Smiseth OA, Mjos OD. A reproducible and stable model of acute ischaemic left ventricular failure in dogs. Clin Physiol 1982;2:225-39.
14. Lavine SJ, Campbell CA, Held AC, Johnson V. Effect of inotropic and vasodilator therapy on left ventricular diastolic filling in dogs with severe left ventricular dysfunction. J Am Coll Cardiol 1990;15:1165-72.
15. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality: CONSENSUS Trial Study Group. Circulation 1990;82:1730-6.
16. Wei CM, Heublein DM, Perrella MA, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-9.
17. Moe GW, Grima EA, Wong NL, Howard RJ, Armstrong PW. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. J Am Coll Cardiol 1996;27:720-7.
18. Suzuki E, Hirata Y, Kohmoto O, et al. Cellular mechanisms for synthesis and secretion of atrial natriuretic peptide and brain natriuretic peptide in cultured rat atrial cells. Circ Res 1992;71:1039-48.
19. Wada A, Tsutamoto T, Matsuda Y, Kinoshita M. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Circulation 1994;89:2232-40.
20. Raine AEG, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986;315:533-7.
21. Redfield MM, Edwards BS, McGoon MD, Heublein DM, Aarhus LL, Burnett JC Jr. Failure of atrial natriuretic factor to increase with volume expansion in acute and chronic congestive heart failure in the dog. Circulation 1989;80:651-7.
22. Gotanda K, Yokoyama H, Satoh K, Taira N. Cardiohemodynamic effects of cromakalim and pinacidil, potassium-channel openers, in the dog, special reference to venous return. Cardiovasc Drugs Ther 1989;3:507-15.
23. Donnelly R, Elliott HL, Meredith PA, Reid JL. Clinical studies with the potassium channel activator cromakalim in normotensive and hypertensive subjects. J Cardiovasc Pharmacol 1990;16:790-5.
24. van Woerkens LJ, Baas NR, van der Giessen WJ, Verdouw PD. Cardiovascular effects of the novel potassium channel opener bimakalim in conscious pigs after myocardial infarction: a comparative study with nicorandil. Cardiovasc Drugs Ther 1992;6:409-17.
25. Thomas P, Dixon MS, Winterton SJ, Sheridan DJ. Acute haemodynamic effects of cromakalim in patients with angina pectoris. Br J Clin Pharmacol 1990;29:325-31.
26. Yanagisawa T, Hashimoto H, Taira N. Interaction of potassium channel openers and blockers in canine atrial muscle. Br J Pharmacol 1989;97:753-62.
27. Wang SY, Manyari DE, Scott-Douglas N, Smiseth OA, Smith ER, Tyberg JV. Splanchnic venous pressure-volume relation during experimental acute ischemic heart failure: differential effects of hydralazine, enalaprilat, and nitroglycerin. Circulation 1995;91: 1205-12.
28. Lewis BS, Makhoul N, Dakak N, et al. Atrial natriuretic peptide in severe heart failure: response to controlled changes in atrial pressures during intravenous nitroglycerin therapy. Am Heart J 1992;124:1009-16.
29. Hashimoto K, Kinoshita K, Ohbayashi Y. Coronary effects of nicorandil in comparison with nitroglycerin in chronic conscious dogs. Cardiovasc Drug Ther 1991;5:131-8.